The Future of Emergency Drug Delivery
Simple Solutions for Critical Moments
DT Therapeutics is developing next-generation microneedle delivery technologies designed to simplify emergency therapeutic administration through precision engineering and intuitive device design.
Why DT Therapeutics?
Simple Solutions for Critical Moments
Every second matters. DT Therapeutics is developing next-generation microneedle technologies designed to simplify emergency therapeutic delivery through precision engineering and intuitive design.
Building the Future of Emergency Medicine
HypoPatch™ Platform
Our next-generation emergency therapeutic delivery platform
Microneedle Platform
The science – Precision-inspired delivery technology.
Engineering & Design
The innovation - Designed for manufacturability, usability and performance.
Development Roadmap
The progress - Advancing from concept through prototype toward future clinical development.
Intellectual Property
DT Therapeutics has filed an Australian provisional patent application relating to proprietary microneedle array architecture and structural innovations. Additional intellectual property development is ongoing as the HypoPatch™ platform evolves.
DEVELOPMENT HIGHLIGHTS
Our Progress, Step by Step
DT Therapeutics is advancing through a structured product development pathway focused on precision engineering, usability and innovation. Each milestone brings us closer to delivering a next-generation platform for emergency therapeutic delivery.
🛡 Intellectual Property
DT Therapeutics has filed an Australian provisional patent application covering proprietary microneedle array architecture and structural innovations.
Concept Development
Status: ✅ Completed
The clinical need, product vision and core platform concept have been established, providing the foundation for the development of the HypoPatch™ technology.
Engineering & Design
Status: ✅ Completed
Initial engineering design and 3D CAD modelling have been completed, enabling iterative refinement of the device architecture, ergonomics and manufacturability.
Prototype Development
Status: 🔄 In Progress
Functional prototypes are currently being developed and refined through rapid design iteration to evaluate usability, engineering performance and manufacturing feasibility.
Design Optimisation
Status: 🟠 Next Phase
Future development will focus on improving ergonomics, manufacturability and overall device performance through continued engineering refinement and prototype optimisation.
Laboratory Evaluation
Status: ⚪ Planned
Future laboratory evaluation is planned to support ongoing technology development and inform subsequent stages of product validation.
Meet our team
DT Therapeutics is led by founder Dan Newen, with a growing network of scientific, clinical and industry advisors.
Dan Nguyen
Founder & Director, Registered Pharmacist
Scientific Advisory Network
Research, formulation and clinical development support
Manufacturing & Industry Partners
Collaborating with manufacturing and engineering partners to advance device development
DT Therapeutics at a Glance
DT Therapeutics is advancing a next-generation emergency drug delivery platform through precision engineering, rapid prototyping and scientific collaboration. Here's a snapshot of where we are today.
Let's Build the Future Together
Whether you're a manufacturer, research organisation, clinician, investor or industry partner, we'd love to hear from you.
General Enquiries
Complete the enquiry form below and we'll respond as soon as possible.